Non-Covid-19 medical device approvals tick up alongside the agency’s pandemic efforts.
2020 was a bountiful year for medtechs making their public debut, with one group, Inari Medical, more than quadrupling in value.
In terms of private investments, 2020 was the year of the liquid biopsy.
It takes more than a pandemic to stop medical device companies merging.